Currently, the most effective treatments for IFN-α-induced depression are selective serotonin reuptake inhibitors (SSRIs), which can be supplemented with hydroxytryptophan and tryptophan [79]. This evidence concerns the gene IFNA1 and depressive symptom measurement.